✦ LIBER ✦

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia

✍ Scribed by Teramoto, Tamio; Shirakawa, Masayoshi; Kikuchi, Masashi; Nakagomi, Mariko; Tamura, Satoko; Surks, Howard K.; McCrary Sisk, Christine; Numaguchi, Hirotaka

Book ID: 122477352
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 379 KB
Volume: 230
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2013.05.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFICACY AND SAFETY OF THE CHOLESTERYL E

EFFICACY AND SAFETY OF THE CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR ANACETRAPIB AS MONOTHERAPY AND COADMINISTERED WITH ATORVASTATIN IN JAPANESE PATIENTS WITH DYSLIPIDEMIA

✍ Teramoto, Tamio; Numaguchi, Hirotaka; Shirakawa, Masayoshi; Kikuchi, Masashi; Na 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Anacetrapib: new hope for cholesteryl es

Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia

✍ Vergeer, Menno; Kastelein, John JP 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Efficacy and safety of the cholesteryl e

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

✍ Daniel Bloomfield; Gary L. Carlson; Aditi Sapre; Diane Tribble; James M. McKenne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 450 KB

Efficacy and safety after cessation of t

Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia

✍ Hayes M. Dansky; Daniel Bloomfield; Patrice Gibbons; Sherry Liu; Christine McCra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Single-dose pharmacokinetics and pharmac

Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

✍ Rajesh Krishna; Amit Garg; Deborah Panebianco; Josee Cote; Arthur J. Bergman; Pa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 874 KB

Multiple-Dose Pharmacodynamics and Pharm

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

✍ Krishna, R; Bergman, AJ; Jin, B; Fallon, M; Cote, J; Van Hoydonck, P; Laethem, T 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 227 KB